← Open Payments lookup

ANDREW JACKENHEIMER: Open Payments

NPI 1346569928 · SEATTLE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,329 in 61 payments from 15 companies in 2025. Trend: 2023 $307 · 2024 $521 · 2025 $1,329

Food & beverage: $1,329
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)14$274
Vanda Pharmaceuticals Inc.8$167
Axsome Therapeutics, Inc.6$154
ABBVIE INC.4$103
Alkermes, Inc.4$101
Janssen Pharmaceuticals, Inc4$99
Otsuka America Pharmaceutical, Inc.4$86
Collegium Pharmaceutical, Inc.4$78
Teva Pharmaceuticals USA, Inc.2$56
Neurocrine BioSciences, Inc.2$49

Products named: CAPLYTA, FANAPT, Auvelity, REXULTI, VRAYLAR, ARISTADA, Jornay PM, AUSTEDO XR.

Industry payments across WA — which companies pay providers there.